Influence of dosage form on the gastroenteropathy of flurbiprofen in the rat: Evidence of shift in the toxicity site

Pharmaceutical Research

Volumn 14, Issue 11, 1997, Pages 1597-1600

  Davies, Neal M ^a   Jamali, Fakhreddin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Flurbiprofen; Gastroduodenal; Intestinal permeability; Non steroidal antiinflammatory drugs

Indexed keywords

ANTIINFLAMMATORY AGENT; EDETATE CHROMIUM CR 51; FLURBIPROFEN; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CAPSULE; ENANTIOMER; GASTROINTESTINAL TOXICITY; INTESTINE MUCOSA PERMEABILITY; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUSTAINED RELEASE FORMULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DUODENUM; FLURBIPROFEN; INTESTINAL ABSORPTION; MALE; POWDERS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH;

EID: 0031455781     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012134503107     Document Type: Article

References (15)

1. M. C. Allison., A. G. Howatson, C. J. Torrance, F. D. Lee, and R. I. Russell. N Engl J Med. 327:749-54 (1992).
2. T. H. Kent, R. M. Cardelli, and F. W. Stamler. Am J Pathol. 54:237-45 (1969).
3. M. A. Trevethick, N. Clayton, P. Strong, and I. Harman. Gut 32:A1224 (1991).
4. I. Bjarnason, P. Williams, P. Smethurst, T. J. Peters, and A. J. Levi. Gut 27:1292-7 (1986).
5. J. B. Meddings, L. R. Sutherland, N. I. Byles, and J. L. Wallace. Gastroenterology 104:1619-26 (1993).
6. J. Ford, S. W. Martin, and J. B. Houston. J Pharm Toxicol Meth 34:9-16 (1995).
7. N. M. Davies, B. Corrigan, and F. Jamali. Pharm. Res 12:1733-6 (1995).
8. N. M. Davies, M. R. Wright, and F. Jamali. Pharm Res 11:1564-9 (1994).
9. T. K. Day. Br Med J 287:1672 (1983).
10. B. W. Berry and Jamali F. Pharm Res 5:123-5 (1988).
11. F. Jamali, B. W. Berry, M. R. Tehrani, and A. S. Russell. J Pharm Sci 77:666-9 (1988).
12. V. M. I. Choi, J. E. Coates, J. Chooi, A. B. R. Thomson, and A. S. Russell. Clin Invest Med 18:357-61 (1995).
13. M. Deakin. Brit Med J 297:488-9 (1988).
14. A. Figueras, D. Capella, J. M. Castel, and J. R. Laporte. Eur J Clin Pharmacol 47:297-303 (1994).
15. N. M. Davies, M. R. Wright, A. S. Russell, and F. Jamali. J Pharm Sc 85:1170-3 (1996).